The Effect of Tranexamic Acid on Calculated Total Blood Loss in Patients undergoing Revision Shoulder Arthroplasty

Brief description of study

The purpose of this research study is to evaluate how well Tranexamic Acid (TXA) reduces total blood loss, surgical drain output (fluids released at the site of surgery) and hematoma (collection of blood outside the vessels) formation in patients undergoing revision shoulder replacements compared to patients who do not receive TXA.


Clinical Study Identifier: s20-01617
ClinicalTrials.gov Identifier: NCT04650698
Principal Investigator: Uchenna O Umeh.


If you are registered as a volunteer, please login to the dashboard to send referrals.

Contact the research team to learn more about this study.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.